Co-delivery of amphotericin B and pentamidine loaded niosomal gel for the treatment of Cutaneous leishmaniasis

References

• Abdelbary A, AbouGhaly M. (2015). Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box–Behnken design, in-vitro evaluation and in-vivo skin deposition study. Int J Pharm 485:1–17.
   PubMedGoogle Scholar
• Adler-Moore J, Lewis RE, Brüggemann RJ, et al. (2019). Preclinical safety, tolerability, pharmacokinetics, pharmacodynamics, and antifungal activity of liposomal amphotericin B. Clin Infect Dis 68:S244–S259.
   PubMed Web of Science ®Google Scholar
• Akbari J, Saeedi M, Enayatifard R, et al. (2020). Curcumin Niosomes (curcusomes) as an alternative to conventional vehicles: a potential for efficient dermal delivery. J Drug Deliv Sci Technol 60:102035.
   Web of Science ®Google Scholar
• Ali Z, Zahid F, Sohail S, et al. (2022). Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout. BMC Pharmacol Toxicol 23:86.
   PubMed Web of Science ®Google Scholar
• Alvar J, Vélez ID, Bern C, et al. (2012). Leishmaniasis worldwide and global estimates of its incidence. PloS One 7:e35671.
   PubMed Web of Science ®Google Scholar
• Alves P, Pohlmann A, Guterres S. (2005). Semisolid topical formulations containing nimesulide-loaded nanocapsules, nanospheres or nanoemulsion: development and rheological characterization. Pharmazie 60:900–4.
   PubMed Web of Science ®Google Scholar
• Andleeb M, Shoaib K, Daniyal M. (2021). Development, characterization and stability evaluation of topical gel loaded with ethosomes containing Achillea millefolium L. Front Pharmacol 12:603227.
   PubMed Web of Science ®Google Scholar
• Bartelds R, Nematollahi MH, Pols T, et al. (2018). Niosomes, an alternative for liposomal delivery. PloS One 13:e0194179.
   PubMed Web of Science ®Google Scholar
• Bae YH, Park K. (2011). Targeted drug delivery to tumors: myths, reality and possibility. J Control Release 153:198–205.
   PubMed Web of Science ®Google Scholar
• Bahraminejad S, Pardakhty A, Sharifi I, et al. (2022). Preparation and evaluation of physicochemical properties and anti-leishmanial activity of zirconium/tioxolone niosomes against Leishmania major. Arab J Chem 15:104156.
   Web of Science ®Google Scholar
• Batool S, Zahid F, Ud-Din F, et al. (2021). Macrophage targeting with the novel carbopol-based miltefosine-loaded transfersomal gel for the treatment of Cutaneous leishmaniasis: in vitro and in vivo analyses. Drug Dev Ind Pharm 47:440–53.
   PubMed Web of Science ®Google Scholar
• Berger J, Reist M, Mayer JM, et al. (2004). Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur J Pharm Biopharm 57:19–34.
   PubMed Web of Science ®Google Scholar
• Bezerra-Souza A, de Jesus JA, Laurenti MD, et al. (2021). Nanoemulsified butenafine for enhanced performance against experimental Cutaneous leishmaniasis. J. Immunol Res 2021:1–13.
   Web of Science ®Google Scholar
• Bhardwaj P, Tripathi P, Gupta R, et al. (2020). Niosomes: a review on niosomal research in the last decade. J Drug Deliv Sci Technol 56:101581.
   Web of Science ®Google Scholar
• Bhardwaj P, Tripathi P, Gupta R, et al. (2020). Niosomes: a review on niosomal research in the last decade. J Drug Delivery Sci Technol 56:101581.
   Web of Science ®Google Scholar
• Bibi M, ud Din F, Anwar Y, et al. (2022). Cilostazol-loaded solid lipid nanoparticles: bioavailability and safety evaluation in an animal model. J Drug Deliv Sci Technol 74:103581.
   Web of Science ®Google Scholar
• Borborema SET, Schwendener RA, Osso JA, et al. (2011). Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages. Int J Antimicrob Agents 38:341–7.
   PubMed Web of Science ®Google Scholar
• Carneiro G, Aguiar MG, Fernandes AP, et al. (2012). Drug delivery systems for the topical treatment of Cutaneous leishmaniasis. Expert Opin Drug Deliv 9:1083–97.
   PubMed Web of Science ®Google Scholar
• Carolus H, Pierson S, Lagrou K, et al. (2020). Amphotericin B and other polyenes—Discovery, clinical use, mode of action and drug resistance. JoF 6:321.
   Google Scholar
• Cerqueira BBS, Lasham A, Shelling AN, et al. (2017). Development of biodegradable PLGA nanoparticles surface engineered with hyaluronic acid for targeted delivery of paclitaxel to triple negative breast cancer cells. Mater Sci Eng C Mater Biol Appl 76:593–600.
   PubMed Web of Science ®Google Scholar
• Chawla V, Saraf SA. (2012). Rheological studies on solid lipid nanoparticle based carbopol gels of aceclofenac. Colloids Surf B Biointerfaces 92:293–8.
   PubMed Web of Science ®Google Scholar
• Chaubey P, Mishra B. (2014). Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis. Carbohydr Polym 101:1101–8.
   PubMed Web of Science ®Google Scholar
• Chen S, Hanning S, Falconer J, et al. (2019). Recent advances in non-ionic surfactant vesicles (niosomes): fabrication, characterization, pharmaceutical and cosmetic applications. Eur J Pharm Biopharm 144:18–39.
   PubMed Web of Science ®Google Scholar
• Choudhury H, Gorain B, Pandey M, et al. (2019). Strategizing biodegradable polymeric nanoparticles to cross the biological barriers for cancer targeting. Int J Pharm 565:509–22.
   PubMedGoogle Scholar
• Clayton KN, Salameh JW, Wereley ST, et al. (2016). Physical characterization of nanoparticle size and surface modification using particle scattering diffusometry. Biomicrofluidics 10:054107.
   PubMed Web of Science ®Google Scholar
• Dar MJ, Din FU, Khan GM. (2018). Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell. Drug Deliv 25:1595–606.
   PubMed Web of Science ®Google Scholar
• Das S, Wong AB. (2020). Stabilization of ferulic acid in topical gel formulation via nanoencapsulation and pH optimization. Sci Rep 10:1–18.
   PubMed Web of Science ®Google Scholar
• Davies JQ, Gordon S. (2009). Isolation and culture of murine macrophages. Methods Mol Biol 290:91–103.
   Google Scholar
• Din FU, Jin SG, Choi H-G. (2021). Particle and gel characterization of irinotecan-loaded double-reverse thermosensitive hydrogel. Polymers 13:551.
   PubMed Web of Science ®Google Scholar
• Gadelha EPN, Ramasawmy R, da Costa Oliveira B, et al. (2018). An open label randomized clinical trial comparing the safety and effectiveness of one, two or three weekly pentamidine isethionate doses (seven milligrams per kilogram) in the treatment of Cutaneous leishmaniasis in the Amazon Region. PLoS Negl Trop Dis 12:e0006850.
   PubMed Web of Science ®Google Scholar
• Ge X, Wei M, He S, et al. (2019). Advances of non-ionic surfactant vesicles (niosomes) and their application in drug delivery. Pharmaceutics 11:55.
   PubMed Web of Science ®Google Scholar
• Groll AH, Rijnders BJ, Walsh TJ, et al. (2019). Clinical pharmacokinetics, pharmacodynamics, safety and efficacy of liposomal amphotericin B. Clin Infect Dis 68:S260–S274.
   PubMed Web of Science ®Google Scholar
• Gugleva V, Titeva S, Rangelov S, et al. (2019). Design and in vitro evaluation of doxycycline hyclate niosomes as a potential ocular delivery system. Int J Pharm 567:118431.
   PubMed Web of Science ®Google Scholar
• Gurjar MS, Ali S, Akhtar M, et al. (2012). Efficacy of plant extracts in plant disease management. AS 03:425–33.
   Google Scholar
• Hafiz S, Kyriakopoulos C. (2020). Pentamidine. Europe PMC.
   Google Scholar
• Hailu A, Gebre-Michael T, Berhe N, et al. (2016). Leishmaniasis. In: Gyapong J, Boatin B, editor. Neglected tropical diseases-sub-Saharan Africa. e-book: Springer. 87–112.
   Google Scholar
• Heidari F, Akbarzadeh I, Nourouzian D, et al. (2020). Optimization and characterization of tannic acid loaded niosomes for enhanced antibacterial and anti-biofilm activities. Adva Powder Technol 31:4768–81.
   Web of Science ®Google Scholar
• Imran B, ud Din F, Ali Z, et al. (2022). Statistically designed dexibuprofen loaded solid lipid nanoparticles for enhanced oral bioavailability. J Drug Deliv Sci and Technol 77:103904.
   Web of Science ®Google Scholar
• Jamshaid H, Din F. u, Khan GM. (2021). Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight. J Nanobiotechnol 19:1–51.
   PubMed Web of Science ®Google Scholar
• Jamshaid H, Din FU, Nousheen K, et al. (2023). Mannosylated imiquimod-terbinafine co-loaded transethosomes for cutaneous leishmaniasis; assessment of its anti-leishmanial potential, in vivo safety and immune response modulation. Biomater Adv 145: 213266.
   PubMedGoogle Scholar
• Jamshaid H, Din F. u, Malik M, et al. (2022). A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c mice. Sci Rep 12:21.
   PubMed Web of Science ®Google Scholar
• Jiao Y, Xie S, Baseer A, et al. (2023). Rectal administration of Celecoxib liquid suppositories with enhanced bioavailability and safety in rats. CDD 20:201–10.
   PubMed Web of Science ®Google Scholar
• Junyaprasert VB, Singhsa P, Suksiriworapong J, et al. (2012). Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid. Int J Pharm 423:303–11.
   PubMed Web of Science ®Google Scholar
• Khan AS, ud Din F, Ali Z, et al. (2021). Development, in vitro and in vivo evaluation of miltefosine loaded nanostructured lipid carriers for the treatment of Cutaneous leishmaniasis. Int J Pharm 593:120109.
   PubMedGoogle Scholar
• Khan AU, Jamshaid H, ud Din F, et al. (2022). Designing, optimization and characterization of Trifluralin transfersomal gel to passively target Cutaneous leishmaniasis. J Pharm Sci 111:1798–811.
   PubMed Web of Science ®Google Scholar
• Khan MM, Zaidi SS, Siyal FJ, et al. (2023). Statistical optimization of co-loaded rifampicin and pentamidine polymeric nanoparticles for the treatment of Cutaneous leishmaniasis. J Drug Delivery Sci Technol 79:104005.
   Web of Science ®Google Scholar
• Khatoon M, Shah KU, Din FU, et al. (2017). Proniosomes derived niosomes: recent advancements in drug delivery and targeting. Drug Deliv 24:56–69.
   PubMed Web of Science ®Google Scholar
• Kumbhar D, Wavikar P, Vavia P. (2013). Niosomal gel of lornoxicam for topical delivery: in vitro assessment and pharmacodynamic activity. AAPS pharmscitech 14:1072–82.
   PubMed Web of Science ®Google Scholar
• Laniado-Laborín R, Cabrales-Vargas MN. (2009). Amphotericin B: side effects and toxicity. Rev Iberoam Micol 26:223–7.
   PubMed Web of Science ®Google Scholar
• Lanza JS, Pomel S, Loiseau PM, et al. (2019). Recent advances in amphotericin B delivery strategies for the treatment of leishmaniases. Expert Opin Drug Deliv 16:1063–79.
   PubMed Web of Science ®Google Scholar
• Maqsood S, Din FU, Khan SU, et al. (2022). Levosulpiride-loaded nanostructured lipid carriers for brain delivery with antipsychotic and antidepressant effects. Life Sci 311:121198.
   PubMed Web of Science ®Google Scholar
• Mesquita JT, Pinto EG, Taniwaki NN, et al. (2013). Lethal action of the nitrothiazolyl-salicylamide derivative nitazoxanide via induction of oxidative stress in Leishmania (L.) infantum. Acta Trop 128:666–73.
   PubMed Web of Science ®Google Scholar
• Mir M, Ishtiaq S, Rabia S, et al. (2017). Nanotechnology: from in vivo imaging system to controlled drug delivery. Nanoscale Res Lett 12:1–16.
   PubMed Web of Science ®Google Scholar
• Moolakkadath T, Aqil M, Ahad A, et al. (2018). Development of transethosomes formulation for dermal fisetin delivery: Box–Behnken design, optimization, in vitro skin penetration, vesicles–skin interaction and dermatokinetic studies. Artif Cells Nanomed Biotechnol 46:755–65.
   PubMed Web of Science ®Google Scholar
• Mostafavi M, Sharifi I, Farajzadeh S, et al. (2019). Niosomal formulation of amphotericin B alone and in combination with glucantime: in vitro and in vivo leishmanicidal effects. Biomed Pharmacother 116:108942.
   PubMed Web of Science ®Google Scholar
• Mushtaq A, Baseer A, Zaidi SS, et al. (2022). Fluconazole-loaded thermosensitive system: In vitro release, pharmacokinetics and safety study. J Drug Deliv Sci Technol 67:102972.
   Web of Science ®Google Scholar
• Nayak D, Tawale RM, Aranjani JM, et al. (2020). Formulation, optimization and evaluation of novel ultra-deformable vesicular drug delivery system for an anti-fungal drug. AAPS PharmSciTech 21:1–10.
   Web of Science ®Google Scholar
• Nowroozi F, Almasi A, Javidi J, et al. (2018). Effect of surfactant type, cholesterol content and various downsizing methods on the particle size of niosomes. Iran J Pharm Res 17:1–11.
   PubMed Web of Science ®Google Scholar
• Obata Y, Utsumi S, Watanabe H, et al. (2010). Infrared spectroscopic study of lipid interaction in stratum corneum treated with transdermal absorption enhancers. Int J Pharm 389:18–23.
   PubMed Web of Science ®Google Scholar
• Paarakh MP, Jose PA, Setty C, et al. (2018). Release kinetics–concepts and applications. Int J Pharm Res Technol 8:12–20.
   Google Scholar
• Parizi MH, Farajzadeh S, Sharifi I, et al. (2019). Antileishmanial activity of niosomal combination forms of tioxolone along with benzoxonium chloride against Leishmania tropica. Korean J Parasitol 57:359–68.
   PubMed Web of Science ®Google Scholar
• Piccica M, Lagi F, Bartoloni A, et al. (2021). Efficacy and safety of Pentamidine isethionate for tegumentary and visceral human leishmaniasis: a systematic review. J Travel Med 6:1–13.
   Google Scholar
• Rabia S, Khaleeq N, Batool S, et al. (2020). Rifampicin-loaded nanotransferosomal gel for treatment of Cutaneous leishmaniasis: passive targeting via topical route. Nanomedicine (Lond) 15:183–203.
   PubMed Web of Science ®Google Scholar
• Romero EL, Morilla MJ. (2008). Drug delivery systems against leishmaniasis? Still an open question. Expert Opin Drug Deliv 5:805–23.
   PubMed Web of Science ®Google Scholar
• Sabir F, Asad MI, Qindeel M, et al. (2019). Polymeric nanogels as versatile nanoplatforms for biomedical applications. J Nanomater 2019:1526186.
   Web of Science ®Google Scholar
• Salim MW, Shabbir K, Yousaf AM, et al. (2020). Preparation, in-vitro and in-vivo evaluation of Rifampicin and Vancomycin Co-loaded transfersomal gel for the treatment of Cutaneous leishmaniasis. J Drug Deliv Sci and Technol 60:101996.
   Web of Science ®Google Scholar
• Sameni J, Krigstin S, Jaffer SA, et al. (2018). Preparation and characterization of biobased microspheres from lignin sources. Ind Crops Prod 117:58–65.
   Web of Science ®Google Scholar
• Scott P, Novais FO. (2016). Cutaneous leishmaniasis: immune responses in protection and pathogenesis. Nat Rev Immunol 16:581–92.
   PubMed Web of Science ®Google Scholar
• Seguella L, Rinaldi F, Marianecci C, et al. (2020). Pentamidine niosomes thwart S100B effects in human colon carcinoma biopsies favouring wtp53 rescue. J Cell Mol Med 24:3053–63.
   PubMed Web of Science ®Google Scholar
• Shahnaz G, Edagwa BJ, McMillan J, et al. (2017). Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis. Nanomedicine (Lond) 12:99–115.
   PubMed Web of Science ®Google Scholar
• Shaji J, Lal M. (2014). Novel double loaded transferosomes: evidence of superior anti-inflammatory efficacy-a comparative study. Int J Curr Pharm Res 6:16–25.
   Google Scholar
• Shirian S, Oryan A, Hatam GR, et al. (2013). Three Leishmania/L. species–L. infantum, L. major, L. tropica–as causative agents of mucosal leishmaniasis in Iran. Pathogens Global Health 107:267–72.
   PubMed Web of Science ®Google Scholar
• Shirsand S, Para M, Nagendrakumar D, et al. (2012). Formulation and evaluation of Ketoconazole niosomal gel drug delivery system. Int J Pharm Investig 2:201–7.
   PubMedGoogle Scholar
• Sohrabi S, Haeri A, Mahboubi A, et al. (2016). Chitosan gel-embedded moxifloxacin niosomes: an efficient antimicrobial hybrid system for burn infection. Int J Biol Macromol 85:625–33.
   PubMed Web of Science ®Google Scholar
• Soto J, Paz D, Rivero D, et al. (2016). Intralesional pentamidine: a novel therapy for single lesions of Bolivian Cutaneous leishmaniasis. Am J Trop Med Hyg 94:852–6.
   PubMed Web of Science ®Google Scholar
• Steverding D. (2017). The history of leishmaniasis. Parasites Vectors 10:1–10.
   PubMed Web of Science ®Google Scholar
• Talebi V, Ghanbarzadeh B, Hamishehkar H, et al. (2021). Effects of different stabilizers on colloidal properties and encapsulation efficiency of vitamin D3 loaded nano-niosomes. J Drug Deliv Sci Technol 61:101284.
   Web of Science ®Google Scholar
• Thabet Y, Elsabahy M, Eissa NG. (2022). Methods for preparation of niosomes: a focus on thin-film hydration method. Methods 199:9–15.
   PubMed Web of Science ®Google Scholar
• Try C, Moulari B, Béduneau A, et al. (2016). Size dependent skin penetration of nanoparticles in murine and porcine dermatitis models. Eur J Pharm Biopharm 100:101–8.
   PubMed Web of Science ®Google Scholar
• ud Din F, Kim DW, Choi JY, et al. (2017). Irinotecan-loaded double-reversible thermogel with improved antitumor efficacy without initial burst effect and toxicity for intramuscular administration. Acta Biomater 54:239–48.
   PubMed Web of Science ®Google Scholar
• ud Din F, Mustapha O, Kim DW, et al. (2015). Novel dual-reverse thermosensitive solid lipid nanoparticle-loaded hydrogel for rectal administration of flurbiprofen with improved bioavailability and reduced initial burst effect. Eur J Pharm Biopharm 94:64–72.
   PubMed Web of Science ®Google Scholar
• ud Din F, Rashid R, Mustapha O, et al. (2015). Development of a novel solid lipid nanoparticles-loaded dual-reverse thermosensitive nanomicelle for intramuscular administration with sustained release and reduced toxicity. RSC Adv 5:43687–94.
   Web of Science ®Google Scholar
• ud Din F, Zeb A, Shah KU. (2019). Development, in-vitro and in-vivo evaluation of ezetimibe-loaded solid lipid nanoparticles and their comparison with marketed product. J Drug Delivery Sci Technol 51:583–90.
   Web of Science ®Google Scholar
• Valenta C. (2005). The use of mucoadhesive polymers in vaginal delivery. Adv Drug Deliv Rev 57:1692–712.
   PubMed Web of Science ®Google Scholar
• Vora B, Khopade AJ, Jain NK. (1998). Proniosome based transdermal delivery of levonorgestrel for effective contraception. J Control Release 54:149–65.
   PubMed Web of Science ®Google Scholar
• Wagh VD, Deshmukh OJ. (2010). Niosomes as ophthalmic drug delivery systems: a review. J Pharm Res 3:1558–63.
   Google Scholar
• Zahid F, Batool S, Ali Z, et al. (2022). Antileishmanial agents co-loaded in transfersomes with enhanced macrophage uptake and reduced toxicity. AAPS PharmSciTech 23:1–18.
   Web of Science ®Google Scholar
• Zeb A, Arif ST, Malik M, et al. (2019). Potential of nanoparticulate carriers for improved drug delivery via skin. J. Pharm Investig 49:485–517.
   Google Scholar
• Zeb A, Qureshi OS, Kim H-S, et al. (2016). Improved skin permeation of methotrexate via nanosized ultradeformable liposomes. Int J Nanomed 11:3813–24.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jing Q, Hu H, et al. (2020). Sodium dodecyl sulfate improved stability and transdermal delivery of salidroside-encapsulated niosomes via effects on zeta potential. Int J Pharm 580:119183.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Ouyang W-Q, Wei Y-P, et al. (2016). Effects of Carbopol® 934 proportion on nanoemulsion gel for topical and transdermal drug delivery: a skin permeation study. Int J Nanomed 11:5971–87.
   PubMed Web of Science ®Google Scholar